Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical organizations, such as the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to accomplish so may be grounds for compensation. Our lawyers are operating hard to acquire these hurt by the drug the compensation they may be entitled to.

While bleeding is actually a frequent complication linked with anticoagulants, it has been alleged that Xarelto is much more hazardous than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This indicates that, in the event of an emergency, sufferers may be at threat for irreversible bleeding difficulties, including life-threatening internal and gastrointestinal hemorrhaging.

In the event you or possibly a loved 1 suffered a critical bleeding event soon after taking Xarelto, you may have legal recourse. For a lot more info, make contact with us today to have your case reviewed, totally free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in instances of death, funeral expenditures. Furthermore, they are in search of punitive damages, which are typically awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can you still get blood clots on xarelto be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.

Visit this page for more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.